Literature DB >> 15882204

Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres.

E Castagnola1, R Haupt, A Micozzi, I Caviglia, A M Testi, F Giona, S Parodi, C Girmenia.   

Abstract

The proportion of ciprofloxacin-resistant Gram-negative bacteria isolated from the blood of children with cancer (not receiving prophylaxis) was 10% in a paediatric hospital (Genoa) where the use of quinolones was highly restricted, compared with 41% in a department of haematology (Rome) where leukaemic adults, who received fluoroquinolone prophylaxis, were also treated (p < 0.0001). Moreover, simultaneous resistance to ciprofloxacin and ceftazidime, amikacin or imipenem-cilastatin was 11% in Genoa compared with 37% in Rome (p < 0.001). Ciprofloxacin resistance was more frequent in children who shared an environment with adults who were receiving ciprofloxacin prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882204     DOI: 10.1111/j.1469-0691.2005.01114.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  11 in total

1.  European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.

Authors:  Diana Averbuch; Christina Orasch; Catherine Cordonnier; David M Livermore; Malgorzata Mikulska; Claudio Viscoli; Inge C Gyssens; Winfried V Kern; Galina Klyasova; Oscar Marchetti; Dan Engelhard; Murat Akova
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

Review 2.  The prevention and management of infections due to multidrug resistant organisms in haematology patients.

Authors:  Jason A Trubiano; Leon J Worth; Karin A Thursky; Monica A Slavin
Journal:  Br J Clin Pharmacol       Date:  2015-02       Impact factor: 4.335

3.  Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia--species distribution and susceptibility patterns.

Authors:  Karin G E Miedema; Rik H L J Winter; Roland A Ammann; Sara Droz; Lodewijk Spanjaard; Eveline S J M de Bont; Willem A Kamps; Marianne D van de Wetering; Wim J E Tissing
Journal:  Support Care Cancer       Date:  2013-04-12       Impact factor: 3.603

4.  Antibacterial prophylaxis in neutropenic children with cancer.

Authors:  Angelica Barone
Journal:  Pediatr Rep       Date:  2011-02-24

5.  The role of prophylaxis of bacterial infections in children with acute leukemia/non-hodgkin lymphoma.

Authors:  Elio Castagnola
Journal:  Pediatr Rep       Date:  2014-06-13

Review 6.  Surveillance of bloodstream infections in pediatric cancer centers - what have we learned and how do we move on?

Authors:  Arne Simon; Rhoikos Furtwängler; Norbert Graf; Hans Jürgen Laws; Sebastian Voigt; Brar Piening; Christine Geffers; Philipp Agyeman; Roland A Ammann
Journal:  GMS Hyg Infect Control       Date:  2016-05-12

Review 7.  Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.

Authors:  Sehnaz Alp; Murat Akova
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-01-01       Impact factor: 2.576

Review 8.  Antibiotic-Resistant Septicemia in Pediatric Oncology Patients Associated with Post-Therapeutic Neutropenic Fever.

Authors:  Rosalino Vázquez-López; Omar Rivero Rojas; Andrea Ibarra Moreno; José Erik Urrutia Favila; Adan Peña Barreto; Guadalupe Lizeth Ortega Ortuño; Jorge Andrés Abello Vaamonde; Ivanka Alejandra Aguilar Velazco; José Marcos Félix Castro; Sandra Georgina Solano-Gálvez; Tomás Barrientos Fortes; Juan Antonio González-Barrios
Journal:  Antibiotics (Basel)       Date:  2019-07-30

Review 9.  Antimicrobial Prophylaxis and Modifications of the Gut Microbiota in Children with Cancer.

Authors:  Gianluca Bossù; Riccardo Di Sario; Alberto Argentiero; Susanna Esposito
Journal:  Antibiotics (Basel)       Date:  2021-02-03

10.  Fluoroquinolone resistance in bacteremic and low risk febrile neutropenic patients with cancer.

Authors:  Sheng Zhang; Qing Wang; Yun Ling; Xichun Hu
Journal:  BMC Cancer       Date:  2015-02-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.